COVID Card Pilot Study to Detect Antibodies to SARS-CoV-2

Completed

Conditions studied: COVID-19, SARS-CoV2 Infection

In brief

This study aims to investigate the clinical performance characteristics of the novel point-of-care, semi-quantitative test for SARS-CoV-2 in the Emergency Department compared to the gold standard (ELISA).

Key facts

Study ID

NCT05196932

Run by

University of Maryland, Baltimore

People needed

56

Starts

2022-08-31

Expected to finish

2023-04-21

Last updated by the study team

2023-05-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Adult (age > 18 years) emergency department patients
• ED workup includes blood testing
• Confirmed history of vaccination against SARS-CoV-2

You may not qualify if…

• Known to be pregnant at the time of evaluation
• Incarcerated at the time of evaluation
• Requires the use of an interpreter
• Patient is considered immunocompromised or has any other condition that the investigator feels makes the patient unsuitable for study inclusion.
• Has any other condition that the investigator feels makes the patient unsuitable for study inclusion

Where it is running

• University of Maryland Medical Systems — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.